Jerry Hadrych, DPM
Podiatrist · Fairmont, WVNPI 1124010459
Payments from drug & device makers
What this record shows
Treace Medical Concepts, Inc. accounts for 65.9% of it on its own, with 18 other manufacturers making up the rest.
Across 112 payments — averaging $45.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$3K
- Organogenesis Inc.$520
- Paratek Pharmaceuticals, Inc.$245
- Amgen$225
- Smith+Nephew$154
- Abbott$130
- plus $479 from 13 others
What the payments were for
- Travel & lodging$2,72653%
- Food & beverage$2,41147%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 26 | $3,383 |
| Organogenesis Inc. | 15 | $520 |
| Paratek Pharmaceuticals, Inc. | 10 | $245 |
| Amgen(2 entities) | 14 | $225 |
| Smith+Nephew | 13 | $154 |
| Abbott | 9 | $130 |
| Cumberland Pharmaceuticals, Inc. | 5 | $71 |
| Kerecis Limited | 4 | $68 |
| Melinta Therapeutics, LLC | 4 | $67 |
| Innovation Technologies Inc | 1 | $67 |
| AbbVie | 3 | $50 |
| Stryker | 1 | $39 |
| Hartmann USA, Inc. | 1 | $22 |
| Integra Lifesciences Corporation | 1 | $21 |
| Arthrosurface Incorporated | 1 | $18 |
| Paragon 28, Inc. | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Mckesson Patient Care Solutions Inc. | 1 | $12 |
| Nevro Corp. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty System$2,171
- LAPIPLASTY SYSTEM 1$620
- PuraPly$108
- PURAPLY WOUND MATRIX$104
How this compares
$5,137 in reported general payments places this provider in the 85th percentile of 37 podiatrist providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Terbinafine Hcl | 48 | $611 |
| Ammonium Lactate | 25 | $476 |
| Cefadroxil | 36 | $421 |
| Gabapentin | 48 | $265 |
| Diclofenac Sodium | 14 | $223 |
| Meloxicam | 46 | $183 |
| Triamcinolone Acetonide | 26 | $143 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 27 | $134 |
| Levofloxacin | 18 | $87 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Fairmont
- Douglas DockeryPrinceton$11K
- Kirt MillerHuntington$6K
- Marian KavanaughWheeling$6K
- Marshal GwynnPrinceton$5K
- Joseph GoodwinWheeling$5K
- Jessica MullinsCharleston$5K
- Vincent OliverioPetersburg$4K
- Dustin PetersonHuntington$3K
- Yuna Farah-PetersonPoint Pleasant$3K
- Gordon MillerMorgantown$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.